# Swiss pharma major Roche on Thursday announced the launch of its atezolizumab injection, Tecentriq SC.

*biotech · news · 2026-05-14 · The Hindu Business Line*

## Key points

- Roche launched Tecentriq SC, a subcutaneous lung cancer treatment, in India for faster administration.
- Tecentriq SC can be administered in as little as seven minutes versus hours for IV infusions.
- The new formulation allows treatment in daycare centers, decentralizing cancer care from tertiary hospitals.
- Each Tecentriq SC injection in India is priced at approximately Rs 3.7 lakh.
- Tecentriq SC enables treating up to five patients in the time of one IV infusion.

**Companies:** Roche
**Countries:** India

[Read the full story on The Hindu Business Line](https://www.thehindubusinessline.com/news/roche-brings-under-the-skin-lung-cancer-treatment-injection-to-india/article70978213.ece)

---

Canonical: https://newsio.io/n/3cd8a152-523c-4040-86d2-4ae55954ce6e/swiss-pharma-major-roche-on-thursday-announced-the-launch-of-its-atezolizumab-in
Summarized by Newsio from The Hindu Business Line. https://newsio.io/how-it-works